NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Tuberculosis Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Tuberculosis Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Tuberculosis



New tuberculosis research reported from University of Alberta



July 13th, 2009

According to recent research published in the International Journal of Tuberculosis and Lung Disease, "Capital Health Tuberculosis (TB) Clinic, Edmonton, Alberta, Canada. To analyze the QuantiFERON (R)-TB Gold In-Tube test (QFT) results after implementation as a routine test for tuberculin skin test (TST) positive patients."

"From November 2004 until January 2007, patients who were TST-positive and were eligible for preventive treatment based on Canadian guidelines, were offered a QFT. Of 1446 TST-positive patients, only 566 (39.6%) were QFT-positive. Categorized by reason for TST testing, 43.1% of 304 contacts, 32.8% of 348 employment screens and 24.2% of 298...


Source: Tuberculosis Week (2009-07-13)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login